Częstość nawrotów AF po przezskórnym zabiegu ablacji. Porównanie ablacji RF oraz krioablacji z doustnymi lekami antyarytmicznymi.
Keywords:
migotanie przedsionków, ablacjaSynopsis
Migotanie przedsionków stanowi najczęstszą tachyarytmię nadkomorową, której leczenie do tej pory polegało na redukcji czynników ryzyka poprzez zmianę stylu życia oraz na kardiowersji farmakologicznej lub elektrycznej. Obecnie coraz częściej stosuję się zabieg ablacji, który ma na celu likwidacje ektopowych ognisk w których dochodzi do generowania nieprawidłowych impulsów. Procedura polega na wprowadzeniu cewnika do jam serca i destrukcję rejonu odpowiedzialnego za powstawanie patologicznych pobudzeń. Obszar ten z czasem fizjologicznie zastępowany jest blizną łącznotkantową. Aktualne techniki takie jak termoablacja i krioablacja istotnie zmniejszają ryzyko nawrotów AF, hospitalizacji, a także wystąpienia poważnych powikłań zagrażających życiu m.in. udar niedokrwienny. Pomimo redukcji wielu czynników ryzyka, techniki ablacji stale związane są z występowaniem powikłań w postaci krwawień czy porażenia nerwu przeponowego. Poza klasycznymi formami ablacji, rozwijane są nowe metody takie jak ablacja polem pulsacyjnym czy nietermiczna elektroporacja, których celem jest przede wszystkim zwiększenie skuteczności zabiegu oraz minimalizowanie powikłań. Niniejszy przegląd przedstawia porównanie najczęściej wykorzystywanych technik ablacji oraz ich skuteczności.
References
Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1). doi:10.1161/CIR.0000000000001193
Bizhanov KA, Аbzaliyev KB, Baimbetov AK, Sarsenbayeva AB, Lyan E. Atrial fibrillation: Epidemiology, pathophysiology, and clinical complications (literature review). J Cardiovasc Electrophysiol. 2023;34(1):153-165. doi:10.1111/jce.15759
Chen S, Chen Y, Yeh H, Tai C, Chen Y, Lin C. Pathophysiology of the Pulmonary Vein as an Atrial Fibrillation Initiator: From Bench to Clinic. Pacing Clin Electrophysiol. 2003;26(7p2):1576-1582. doi:10.1046/j.1460-9592.2003.t01-1-00235.x
Camm AJ, Naccarelli GV, Mittal S, et al. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2022;79(19):1932-1948. doi:10.1016/j.jacc.2022.03.337
Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305-1316. doi:10.1056/NEJMoa2019422
Chyou JY, Barkoudah E, Dukes JW, et al. Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association. Circulation. 2023;147(15). doi:10.1161/CIR.0000000000001133
Anselmino M, D’Ascenzo F, Amoroso G, Ferraris F, Gaita F. History of transcatheter atrial fibrillation ablation: J Cardiovasc Med. 2012;13(1):1-8. doi:10.2459/JCM.0b013e32834ead59
Scheinman MM. The first ablation. Heart Rhythm. 2024;21(5):519-520. doi:10.1016/j.hrthm.2024.02.058
Ward RC, DeSimone CV. Pulsed field electroporation for pulmonary vein isolation—continued innovation to improve our atrial fibrillation armamentarium. J Interv Card Electrophysiol. 2022;66(7):1541-1543. doi:10.1007/s10840-022-01418-3
Pfeiffer D, Tebbenjohanns J, Klein N, Metze M, Neef M. Geschichte der Katheterablation. Herzschrittmachertherapie Elektrophysiologie. 2019;30(4):325-329. doi:10.1007/s00399-019-00661-y
Chew DS, Black-Maier E, Loring Z, et al. Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis of Observational Studies. Circ Arrhythm Electrophysiol. 2020;13(4):e008128. doi:10.1161/CIRCEP.119.008128
Razzack AA, Lak HM, Pothuru S, et al. Efficacy and Safety of Catheter Ablation vs Antiarrhythmic Drugs as Initial Therapy for Management of Symptomatic Paroxysmal Atrial Fibrillation: A Meta-Analysis. Rev Cardiovasc Med. 2022;23(3):112. doi:10.31083/j.rcm2303112
Chew DS, Li Y, Cowper PA, et al. Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial. Circulation. 2022;146(7):535-547. doi:10.1161/CIRCULATIONAHA.122.058575
Duncker D, Sommer P, Busch S, et al. Punktionstechniken in der invasiven Elektrophysiologie. Herzschrittmachertherapie Elektrophysiologie. 2021;32(2):274-284. doi:10.1007/s00399-021-00761-8
Iden L, Busch S, Steven D, et al. Pulmonalvenenisolation mittels Radiofrequenzablation. Herzschrittmachertherapie Elektrophysiologie. 2021;32(3):395-405. doi:10.1007/s00399-021-00794-z
El Baba M, Sabayon D, Refaat M. Radiofrequency Catheter Ablation: How to Manage and Prevent Collateral Damage? J Innov Card Rhythm Manag. 2020;11(9)::4234-4240. doi:10.19102/icrm.2020.110901
Turagam MK, Musikantow D, Whang W, et al. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials. JAMA Cardiol. 2021;6(6):697. doi:10.1001/jamacardio.2021.0852
Mao Y jun, Wang H, Chen J xing, Huang P fang. Meta-analysis of medical management versus catheter ablation for atrial fibrillation. Rev Cardiovasc Med. 2020;21(3):419. doi:10.31083/j.rcm.2020.03.60
Monahan KH, Bunch TJ, Mark DB, et al. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA. Europace. 2022;24(9):1430-1440. doi:10.1093/europace/euac055
Kheshti F, Abdollahifard S, Hosseinpour A, Bazrafshan M, Attar A. Ablation versus medical therapy for patients with atrial fibrillation: An updated meta‐analysis. Clin Cardiol. 2024;47(2):e24184. doi:10.1002/clc.24184
Chander S, Kumari R, Luhana S, et al. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2024;24(1):321. doi:10.1186/s12872-024-03983-z
Waranugraha Y, Tsai CT, Lin LY. Index-Guided High-Power Radiofrequency Catheter Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis Study. Curr Cardiol Rep. 2023;25(11):1397-1414. doi:10.1007/s11886-023-01968-6
Poole JE, Bahnson TD, Monahan KH, et al. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. J Am Coll Cardiol. 2020;75(25):3105-3118. doi:10.1016/j.jacc.2020.04.065
Kuck KH, Lebedev DS, Mikhaylov EN, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). EP Eur. 2021;23(3):362-369a. doi:10.1093/europace/euaa298
Xu M, Yang Y, Zhang D, Jiang W. Meta-analysis of high power short duration in atrial fibrillation ablation – a superior efficient ablation strategy. Acta Cardiol. 2022;77(1):14-32. doi:10.1080/00015385.2021.1939512
Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore-India, Khanra D, et al. Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation. Anatol J Cardiol. 2022;26(1):2-14. doi:10.5152/AnatolJCardiol.2021.243
Cui L, Chu Y, Han Y, Dong S. Comparison of higher-power and conventional power ablation of atrial fibrillation using contact force-sensing catheters: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2021;62(1):1-7. doi:10.1007/s10840-021-00975-3
Kewcharoen J, Techorueangwiwat C, Kanitsoraphan C, et al. High‐power short duration and low‐power long duration in atrial fibrillation ablation: A meta‐analysis. J Cardiovasc Electrophysiol. 2021;32(1):71-82. doi:10.1111/jce.14806
Joza J, Nair GM, Birnie DH, et al. High‐power short‐duration versus low‐power long‐duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial. J Cardiovasc Electrophysiol. 2024;35(1):136-145. doi:10.1111/jce.16123
Andrade JG. Cryoablation for atrial fibrillation. Heart Rhythm O2. 2020;1(1):44-58. doi:10.1016/j.hroo.2020.02.004
Yacoub M, Sheppard RC. Cryoballoon Pulmonary Vein Catheter Ablation of Atrial Fibrillation. In: StatPearls. StatPearls Publishing; 2025. Accessed February 6, 2025. http://www.ncbi.nlm.nih.gov/books/NBK534804/
Andrade JG, Deyell MW, Macle L, et al. Progression of Atrial Fibrillation after Cryoablation or Drug Therapy. N Engl J Med. 2023;388(2):105-116. doi:10.1056/NEJMoa2212540
Imberti JF, Ding WY, Kotalczyk A, et al. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021;107(20):1630-1636. doi:10.1136/heartjnl-2021-319496
Deshpande R, AlKhadra Y, Singanallur P, Botchway A, Labedi M. Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2022;65(3):773-802. doi:10.1007/s10840-022-01365-z
Liu Z, Yang Z, Lu Y, Wang H, Zou C. Short‐term and long‐term effects of cryoballoon ablation versus antiarrhythmic drug therapy as first‐line treatment for paroxysmal atrial fibrillation: A systematic review and meta‐analysis. Clin Cardiol. 2023;46(10):1146-1153. doi:10.1002/clc.24092
Song W, Lv T, Zhang N, Li G, Tse G, Liu T. Long‐term efficacy and safety of cryoballoon ablation of atrial fibrillation: A systematic review and meta‐analysis. Pacing Clin Electrophysiol. 2024;47(1):49-57. doi:10.1111/pace.14881
Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. N Engl J Med. 2021;384(4):305-315. doi:10.1056/NEJMoa2029980
Ravi V, Poudyal A, Pulipati P, et al. A systematic review and meta‐analysis comparing second‐generation cryoballoon and contact force radiofrequency ablation for initial ablation of paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31(10):2559-2571. doi:10.1111/jce.14676
Wang Y, Wang W, Yao J, Chen L, Yi S. Second-generation cryoballoon vs. contact-force sensing radiofrequency catheter ablation in atrial fibrillation: a meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2021;60(1):9-19. doi:10.1007/s10840-020-00893-w
Liu XH, Gao XF, Jin CL, Chen CF, Chen B, Xu YZ. Cryoballoon versus radiofrequency ablation for persistent atrial fibrillation: a systematic review and meta‑analysis. Kardiol Pol. 2020;78(1):20-29. doi:10.33963/KP.15048
Kim JA, Chelu MG. Comparison of cryoballoon and radiofrequency ablation for persistent atrial fibrillation: a systematic review and meta-analysis. J Interv Card Electrophysiol. Published online September 12, 2022. doi:10.1007/s10840-022-01369-9
Ullah W, Johnson D, Nair AS, et al. Ablation Versus Antiarrhythmic Drugs as First-Line Therapy for Treatment-Naive Atrial Fibrillation: A Systematic Review and Meta-Analysis. Am J Cardiol. 2024;213:63-68. doi:10.1016/j.amjcard.2023.11.052
Lin L, Huang Y, Huang Q, Yu F, Mao Y. Meta‐analysis of high‐power short‐duration versus cryoballoon ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2024;47(8):1013-1024. doi:10.1111/pace.15004
Mao Y jun, Ai L jing, Cai Y hui, et al. Indirect Comparison of Cryoablation and Radiofrequency Ablation as Initial Therapy for Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Cardiology. 2023;148(2):138-149. doi:10.1159/000528758
Fong KY, Zhao JJ, Chan YH, Wang Y, Yeo C, Tan VH. Ablation therapies for paroxysmal atrial fibrillation: A systematic review and patient-level network meta-analysis. Ann Acad Med Singapore. 2023;52(1):27-40. doi:10.47102/annals-acadmedsg.2022326
Reddy VY, Gerstenfeld EP, Natale A, et al. Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2023;389(18):1660-1671. doi:10.1056/NEJMoa2307291
Aldaas OM, Malladi C, Han FT, et al. Pulsed field ablation versus thermal energy ablation for atrial fibrillation: a systematic review and meta-analysis of procedural efficiency, safety, and efficacy. J Interv Card Electrophysiol. 2023;67(3):639-648. doi:10.1007/s10840-023-01660-3
Reddy VY, Calkins H, Mansour M, et al. Pulsed Field Ablation to Treat Paroxysmal Atrial Fibrillation: Safety and Effectiveness in the AdmIRE Pivotal Trial. Circulation. 2024;150(15):1174-1186. doi:10.1161/CIRCULATIONAHA.124.070333
Reddy VY, Mansour M, Calkins H, et al. Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation. J Am Coll Cardiol. 2024;84(1):61-74. doi:10.1016/j.jacc.2024.05.001
Zhang H, Zhang H, Lu H, Mao Y, Chen J. Meta‐analysis of pulsed‐field ablation versus cryoablation for atrial fibrillation. Pacing Clin Electrophysiol. 2024;47(5):603-613. doi:10.1111/pace.14971
Vetta G, Della Rocca DG, Parlavecchio A, et al. Multielectrode catheter-based pulsed electric field vs. cryoballoon for atrial fibrillation ablation: a systematic review and meta-analysis. Europace. 2024;26(12):euae293. doi:10.1093/europace/euae293
Ioannou A, Papageorgiou N, Lim WY, et al. Efficacy and safety of ablation index-guided catheter ablation for atrial fibrillation: an updated meta-analysis. EP Eur. 2020;22(11):1659-1671. doi:10.1093/europace/euaa224
Jiang R, Chen M, Fan J, et al. Efficacy of ablation index‐guided pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2022;45(10):1186-1193. doi:10.1111/pace.14578
Rivera A, Gewehr DM, Braga MAP, et al. Adjunctive low‐voltage area ablation for patients with atrial fibrillation: An updated meta‐analysis of randomized controlled trials. J Cardiovasc Electrophysiol. 2024;35(7):1329-1339. doi:10.1111/jce.16290
Saglietto A, Ballatore A, Gaita F, et al. Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials. Eur Heart J - Qual Care Clin Outcomes. 2022;8(6):619-629. doi:10.1093/ehjqcco/qcab066
Published
August 6, 2025
Copyright (c) 2025 Robert Kasza; Lidia Ziętek, Barbara Grochowska
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
